Biologic could reduce treatment burden for children with haemophilia A
By Catherine Eckford (European Pharmaceutical Review)
Unlocking intellectual property potential in European pharma
By Joshua Harris (Burford Capital)
Draft regulatory guidance on personalised cancer therapies published
By Catherine Eckford (European Pharmaceutical Review)
Moderna reports record for UK clinical trials in 2023/24
By Catherine Eckford (European Pharmaceutical Review)
Harnessing industry advancements to accelerate upstream process development
By Dr Li Yang (Altruist Biologics), Dr Shidong Shi (Altruist…
Considerations for a successful tech transfer of a biologics upstream…
By Maolong Liu (Lonza Biologics), Neil Judd (Lonza), Nikki Nogal…